Allan Gibofsky, MD, JD

Allan Gibofsky, MD, JD


Allan Gibofsky, MD, JD is Professor of Medicine and Public Health at Weill Medical College of Cornell University and Adjunct Professor of Law at Fordham University  School of Law.  He is an Attending Physician and Rheumatologist at The New York Presbyterian Hospital and Hospital for Special Surgery, where he is Co-Director of the Center for Inflammatory Arthritis and Biologic Therapy.

Dr. Gibofsky received his undergraduate degree from Brooklyn College of the City University of New York , his MD from Weill Medical College of Cornell University and his law degree from Fordham University. He did his internship in Pathology, followed by a residency in Medicine at New York Hospital. He completed a fellowship in Rheumatology/Immunology jointly at Hospital for Special Surgery and at The Rockefeller University. Dr. Gibofsky has authored or co-authored numerous papers and text chapters, primarily on the immunogenetics of rheumatic diseases and legal aspects of medical practice. He is known for his work on mechanisms of host-microbe interactions in rheumatology, and, in particular for his basic and clinical studies on rheumatic fever as well as for his work on therapeutic strategies in the treatment of inflammatory rheumatic diseases.

Currently Secretary-Treasurer of The New York Rheumatism Association, Dr. Gibofsky is past-Chair of the Medical & Scientific Committee of the New York Chapter of The Arthritis Foundation and received their Physicians’ Leadership Award. He also served as a member of the local and national Arthritis Foundation Board of Trustees, and was Chair for Professional Education. Dr. Gibofsky has participated   in numerous professional and public education programs, nationally and internationally. He is a past president of the American College of Legal Medicine, and is past Chair of the American Board of Legal Medicine.  In 2002, Dr. Gibofsky served as President of The American College of Rheumatology.

Dr. Gibofsky is a Jonas Salk Scholar of the City University and in 1997 he was named Alumnus of the Year by Brooklyn College.


  1. Anwar S, Gibofsky A: Musculoskeletal manifestations of thyroid disease.   Rheum  Dis Clin North America  36:637-646. 2010.
  2. Gibofsky A, Palmer WR, Keystone EC, Schiff MF, Feng J, McCroskery P, Baumgartner SW, Markenson JA: Rheumatoid arthritis disease modifying anti-rheumatic drug intervention and utilization study: Safety and etanercept utilization from the RADIUS 1 and RADIUS 2 registries: J Rheum  38: 21-28.2011.
  3. Dworkin RH, Peirce-Sandner S, Turk DC, McDermott MP, Gibofsky A, Simon LS, Farrar JT, Katz N: Outcomes measures in placebo-controlled trials of osteoarthritis: Responsiveness to treatment effects in the REPORT database.  Manuscript Submitted. Osteoarthritis and Cartilage 2010.
  4. Singer O, Gibofsky A: Methotrexate versus leflunomide; what’s new in 2011. Manuscript accepted. Curr Opin Rheum 2011.
  5. Markenson JA, Gibofsky A, Palmer WA, Keystone EC, Schiff M, Feng J, Baumgartner S: Persistence with anti-TNF therapies in patients with rheumatoid arthritis: observations  from the RADIUS registry. In press. J Rheum 2011.
  6. Bernstein E, Gibofsky A: Treating rheumatoid rrthritis to target: The time has come. Manuscript submitted. The Rheumatologist 2011.


Bookmark and Share